Arizona State University
Tempe, Arizona, 85287, United States
NCT Number: NCT01225198
The investigators hypothesis is that a new, revised formulation of a vitamin/mineral supplement will result in:
1. improvement of nutritional status in some children/adults with autism, and 2. reduction of some of the symptoms of autism in some children
Looking for future studies?
Notify Me3 year–60 year
All sexes
Interventional
Phase 2
Tempe, Arizona, 85287, United States
The major goal of this study is to determine the effect of this vitamin/mineral supplement on levels of vitamins, minerals, neurotransmitters, and biomarkers for nutritional deficiencies. The study design is a randomized, double-blind, placebo-controlled. Blood and urine measurements will be measured at the beginning of the study in children with autism and typical children. Then, the children with autism will be given the supplement or placebo for 12 weeks, and then their blood and urine will be re-measured.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A broad-spectrum vitamin/mineral supplement designed for children and adults with autism
The placebo was formulated to look and taste like the intervention supplement. A small amount of beta-carotene was used for coloring. Natural cherry, citric acid, and a proprietary blend of natural flavors were used for flavoring to create a vitamin-like after-taste. Sucralose was used as a sweetener and the same preservatives were included (potassium sorbate, sodium benzoate).
Time frame: Beginning of study (day 0)
Level of Plasma Nitrotyrosine
Time frame: End of Study (after 12 weeks of treatment)
Level of plasma nitrotyrosine
Time frame: End of study (12 weeks)
The Average Change of the Parent Global Impressions (PGI-R) assessment tool.
Arizona State University
Other
New Vitamin/Mineral Supplement for Children and Adults With Autism - National Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06875843
Animal Communication, Autism
Nashville, Tennessee, United States
View Trial DetailsNCT06221176
Autism, Autism Spectrum Disorder
Brookline, Massachusetts, United States
View Trial DetailsNCT05862467
Autism, Autism Spectrum Disorder
Laramie, Wyoming, United States
View Trial DetailsNCT06207149
Autism, Autism Spectrum Disorder
Champaign, Illinois, United States
View Trial Details